摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-羟基倍他米松 | 24703-00-2

中文名称
6-羟基倍他米松
中文别名
——
英文名称
6β-hydroxybetamethasone
英文别名
6-Hydroxybetamethasone;(6R,8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-6,11,17-trihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
6-羟基倍他米松化学式
CAS
24703-00-2
化学式
C22H29FO6
mdl
——
分子量
408.467
InChiKey
RVBSTEHLLHXILB-DNVCMXBESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    >248°C (dec.)
  • 沸点:
    613.2±55.0 °C(Predicted)
  • 密度:
    1.38±0.1 g/cm3(Predicted)
  • 溶解度:
    可溶于丙酮(轻微,超声处理)、DMSO(轻微)、甲醇(轻微)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    29
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.73
  • 拓扑面积:
    115
  • 氢给体数:
    4
  • 氢受体数:
    7

SDS

SDS:bf4a3266c15bc7fcd7884d36ddf40e8a
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    倍他米松二丙酸酯 在 phosphate buffer 、 air 、 plasma of 20 d pregnant Sprague-Dawley rat 作用下, 反应 1.0h, 以67.8%的产率得到9-氟-11beta,17,21-三羟基-16beta-甲基孕甾-1,4-二烯-3,20-二酮 17-丙酸酯
    参考文献:
    名称:
    Correlation between metabolism of betamethasone 17,21-dipropionate and adrenal hypertrophy in rat fetuses
    摘要:
    The effects of metabolites of betamethasone 17,21-dipropionate (BMDP) on the hypothalamo-pituitary-adrenocortical axis were assessed by measurements of adrenal weights, after studying the metabolism of BMDP in vivo and in vitro in pregnant rats and mice. After BMDP was injected intravenously at a dose of 5 mg/kg into rats and mice in late stages of pregnancy, it disappeared rapidly from the plasma and brain stages of pregnancy, it disappeared rapidly from the plasma and brain in both mothers and fetuses while betamethasone 17-propionate (BMP) was detected as the main metabolite followed by betamethasone (BM). In vitro studies demonstrated that BMDP was metabolized to BMP in maternal and fetal tissues (plasma, liver, brain and placenta) of both species. The subcutaneous administration of BMP to rats in the late stages of pregnancy induced adrenal hypertrophy in fetuses, though the adrenals of the mothers became atrophic. In the case of mice, both maternal and fetal adrenals became atrophic. Administration of BM produced adrenal atrophy in mothers and fetuses of both species. The subcutaneous administration of 6 beta-hydroxybetamethasone 17-propionate (6 beta-OH-BMP) to rat fetuses in utero produced adrenal hypertrophy and 6 beta-hydroxybetamethasone (6 beta-OH-BM) showed no effect. These data suggest that BMP is transferred across the placental barrier to produce marked adrenal hypertrophy in rat fetuses.
    DOI:
    10.1016/s0039-128x(81)90348-2
点击查看最新优质反应信息

文献信息

  • Correlation between metabolism of betamethasone 17,21-dipropionate and adrenal hypertrophy in rat fetuses
    作者:Masayuki Nakano、Masanori Nishiuchi、Masaharu Takeuchi、Hideo Yamada
    DOI:10.1016/s0039-128x(81)90348-2
    日期:1981.5
    The effects of metabolites of betamethasone 17,21-dipropionate (BMDP) on the hypothalamo-pituitary-adrenocortical axis were assessed by measurements of adrenal weights, after studying the metabolism of BMDP in vivo and in vitro in pregnant rats and mice. After BMDP was injected intravenously at a dose of 5 mg/kg into rats and mice in late stages of pregnancy, it disappeared rapidly from the plasma and brain stages of pregnancy, it disappeared rapidly from the plasma and brain in both mothers and fetuses while betamethasone 17-propionate (BMP) was detected as the main metabolite followed by betamethasone (BM). In vitro studies demonstrated that BMDP was metabolized to BMP in maternal and fetal tissues (plasma, liver, brain and placenta) of both species. The subcutaneous administration of BMP to rats in the late stages of pregnancy induced adrenal hypertrophy in fetuses, though the adrenals of the mothers became atrophic. In the case of mice, both maternal and fetal adrenals became atrophic. Administration of BM produced adrenal atrophy in mothers and fetuses of both species. The subcutaneous administration of 6 beta-hydroxybetamethasone 17-propionate (6 beta-OH-BMP) to rat fetuses in utero produced adrenal hypertrophy and 6 beta-hydroxybetamethasone (6 beta-OH-BM) showed no effect. These data suggest that BMP is transferred across the placental barrier to produce marked adrenal hypertrophy in rat fetuses.
查看更多